ANLN and laryngeal carcinoma: Consistently, the results showed that ANLN-201 was expressed in almost all of the tested tumor cell lines whereas the ANLN-210 was only expressed in the following cell lines, including the hypopharyngeal carcinoma cell line FaDu, the two tongue squamous cell lines SCC-9 and SCC-15, and the laryngeal carcinoma cell line SNU899 (Fig. 1D).